SSSubhashree Samantaray

Subhashree Samantaray

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Subhashree Samantaray has a total of 32 co-authors. Here are the top co-authors by number of shared publications:

  • Deepak Kumar

    Department of Medicine and Infectious Diseases, All India Institute of Medical Science , Jodhpur, Rajasthan

    5 shared publications
  • Gopal Krishana Bohra

    Department of General Medicine (Infectious Diseases), All India Institute of Medical Sciences, Jodhpur, Rajasthan, India

    5 shared publications
  • Mahendra Kumar Garg

    Department of General Medicine (Infectious Diseases), All India Institute of Medical Sciences, Jodhpur, Rajasthan, India

    5 shared publications
  • Shivang Sharma

    Department of General Medicine (Infectious Diseases), All India Institute of Medical Sciences, Jodhpur, Rajasthan, India

    5 shared publications
  • Durga Shankar Meena

    Department of General Medicine (Infectious Diseases), All India Institute of Medical Sciences, Jodhpur, Rajasthan, India

    4 shared publications
  • Rahul Chaudhary

    Department of Cardiology, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India

    4 shared publications

Latest Publications

  • Non-tuberculous Mycobacteria Osteomyelitis of Patella with Prepatellar Bursitis of Knee

    by Ashish Garg, Alisha Aggarwal, Vikarn Vishwajeet, Subhashree Samantaray

    Tuberculosis has been persisting with mankind since time immemorial, which delineates its ubiquitous nature. However, infections with non-tubercular mycobacteria of musculoskeletal tissue are rare. Though the knee joint is the third most common site of involvement after the spine and hip, atypical mycobacterial infection of the patella in an immunocompetent patient is unheard of. Herein, we present a case of a late adolescent male with diffuse painful swelling of the left knee, which came to be diagnosed as Non-tuberculous Mycobacteria osteomyelitis of the patella left side for its rarity and its successful management by antitubercular chemotherapy without any surgical intervention. High suspicion, early diagnosis and anti-NTM chemotherapy bring satisfactory outcomes.

  • Open Access

    Prosthetic valve endocarditis due to Candida parapsilosis – a rare case report

    by Shivang Sharma, Subhashree Samantaray, Deepak Kumar, Durga Shankar Meena, Rahul Chaudhary, Vidhi Jain, Gopal Krishana Bohra, Mahendra Kumar Garg

    Fungal endocarditis is a rare and fatal condition, most frequently caused by species of the genera Candida and Aspergillus. Fever and changing heart murmur are the most common clinical manifestations. The diagnosis of fungal endocarditis is challenging, with prosthetic valve endocarditis being extremely difficult to diagnose. The optimal management of the condition still remains debatable. We present a case of prosthetic valve endocarditis caused by Candida parapsilosis, managed empirically with liposomal amphotericin B, which was later shifted to combination therapy with high-dose echinocandin and fluconazole, but had a fatal outcome because the patient could not undergo timely surgical intervention. Treating C. parapsilosis endocarditis cases is difficult because of their biofilm production on native and prosthetic heart valves. A combined approach consisting of a high index of clinical suspicion, early diagnosis using serological markers followed by culture or PCR and prompt initiation of appropriate antifungals may aid in improving outcomes.


  • Open Access

    Prosthetic valve endocarditis due to Candida parapsilosis- a rare case report

    by Shivang Sharma, Subhashree Samantaray, Deepak Kumar, Durga Shankar Meena, Rahul Chaudhary, Vidhi Jain, Gopal Krishana Bohra, Mahendra Kumar Garg

    Fungal endocarditis is a rare and fatal condition , most frequently caused by the Candida and Aspergillus species. Fever and changing heart murmur are the most common clinical manifestations. The diagnosis of fungal endocarditis is challenging, especially that of prosthetic valve endocarditis is extremely difficult. The optimal management of the condition still remains debatable. We hereby present a case of prosthetic valve endocarditis caused by Candida parapsilosis , managed empirically with liposomal amphotericin B and later on was shifted to combination therapy with high dose echinocandin and fluconazole, but had a fatal outcome because he could not undergo timely surgical intervention. Treating Candida parapsilosis endocarditis cases are difficult because of their ability of biofilm production on native and prosthetic heart valves. A combined approach consisting of high index of clinical suspicion, early diagnosis by using serological markers followed by culture or PCR and prompt initiation of appropriate antifungals may aid in improving the outcome.

  • Open Access

    Prosthetic valve endocarditis due to Candida parapsilosis- a rare case report

    by Shivang Sharma, Subhashree Samantaray, Deepak Kumar, Durga Shankar Meena, Rahul Chaudhary, Vidhi Jain, Gopal Krishana Bohra, Mahendra Kumar Garg

    Fungal endocarditis is a rare and fatal condition , most frequently caused by the Candida and Aspergillus species. Fever and changing heart murmur are the most common clinical manifestations. The diagnosis of fungal endocarditis is challenging, especially that of prosthetic valve endocarditis is extremely difficult. The optimal management of the condition still remains debatable. We hereby present a case of prosthetic valve endocarditis caused by Candida parapsilosis , managed empirically with liposomal amphotericin B and later on was shifted to combination therapy with high dose echinocandin and fluconazole, but had a fatal outcome because he could not undergo timely surgical intervention. Treating Candida parapsilosis endocarditis cases are difficult because of their ability of biofilm production on native and prosthetic heart valves. A combined approach consisting of high index of clinical suspicion, early diagnosis by using serological markers followed by culture or PCR and prompt initiation of appropriate antifungals may aid in improving the outcome.

  • Prevalence, Presentation and Outcome of Secondary Bloodstream Infections among COVID-19 Patients

    by Subhashree Samantaray, Priyabrat Karan, Anuradha Sharma, Vijayalakshmi Nag, Naveen Dutt, Mahendra Kumar Garg, Pradeep Kumar Bhatia, Sanjeev Misra

    Background: The higher mortality rate in COVID-19 patients is still a concern. Though some studies mention that elderly patients with co-morbidities are at higher risk of mortality, some others report uneventful outcomes in young patients even without co-morbidities. Secondary bacterial and fungal infections, especially with nosocomial pathogens are known to be associated with worse outcome in the ongoing pandemic as well as in the previous viral outbreaks. In such a scenario, the outcome of hospitalized COVID-19 patients can be improved by timely identification of secondary infections using appropriate biomarkers and by following appropriate infection control measures to prevent the spread of nosocomial pathogens. Objective: The study aims to find out the prevalence of bloodstream infections (BSI) among hospitalized COVID-19 patients and to analyze their laboratory markers and outcome by comparing them with those without BSI. Methods: In this descriptive cross-sectional study, the prevalence of secondary BSI was determined among the hospitalized COVID-19 patients by including 388 blood culture bottles collected from 293 patients, which were received in the microbiology lab within the study period. Results: The overall prevalence of BSI in COVID-19 patients was 39.5% (116/293), out of which 35.5% (104/293) infections were bacterial, and 4.1% (12/293) were fungal, while 8.9% (26/293) patients grew contaminants, and 51.5% (151/293) were sterile. Common causative agents of secondary BSI were found to be MDR Klebsiella pneumoniae (10.9%) and Acinetobacter baumannii (8.8%) followed by Candida species (4.1%). Patients with co-morbidities like diabetes, hypertension and COPD were at higher risk of developing BSI with significantly higher levels of sepsis markers such as Creactive protein (CRP), procalcitonin, ferritin and Interleukin-6 (IL-6). The mortality rate was significantly higher (60.2%) in patients with BSI compared to the group of patients without BSI. Conclusion: Our findings suggest the necessity of early diagnosis of the secondary infections using appropriate biomarkers and following proper infection control measures to prevent the spread of the nosocomial infections and improve the outcome of hospitalized COVID-19 patients.


  • Open Access

    Prosthetic valve endocarditis due to Candida parapsilosis- a rare case report

    by Shivang Sharma, Subhashree Samantaray, Deepak Kumar, Durga Shankar Meena, Rahul Chaudhary, Vidhi Jain, Gopal Krishana Bohra, Mahendra Kumar Garg

    Fungal endocarditis is a rare and fatal condition , most frequently caused by the Candida and Aspergillus species. Fever and changing heart murmur are the most common clinical manifestations. The diagnosis of fungal endocarditis is challenging, especially that of prosthetic valve endocarditis is extremely difficult. The optimal management of the condition still remains debatable. We hereby present a case of prosthetic valve endocarditis caused by Candida parapsilosis , managed empirically with liposomal amphotericin B and later on was shifted to combination therapy with high dose echinocandin and fluconazole, but had a fatal outcome because he could not undergo timely surgical intervention. Treating Candida parapsilosis endocarditis cases are difficult because of their ability of biofilm production on native and prosthetic heart valves. A combined approach consisting of high index of clinical suspicion, early diagnosis by using serological markers followed by culture or PCR and prompt initiation of appropriate antifungals may aid in improving the outcome.

  • Evaluation of MALDI-TOF MS for Identification of Species in the Candida parapsilosis Complex from Candidiasis Cases

    by Subhashree Samantaray, Rakesh Singh

    Background: Phenotypically identified Candida parapsilosis is actually a complex of 3 member species named Candida parapsilosis sensu stricto (CPSS), Candida orthopsilosis (CO), and Candida metapsilosis (CM), which can be identified only by molecular methods and automated methods such as MALDI-TOF mass spectrometry (MS). This study was undertaken to evaluate the VITEK MS, which uses the principle of MALDI-TOF MS for the identification of member species of C. parapsilosis complex (CPC). Methods: In this cross-sectional study, 126 presumptively identified and stocked isolates of CPC were included. Definite identification to species level was done by VITEK MS and PCR as the gold standard method. Clinico-demographic characters and risk factors were analyzed. Antifungal susceptibility testing was performed for fluconazole and voriconazole. Results: Twelve isolates were not identified as CPC either by VITEK MS or PCR and hence were excluded from the analysis. Out of 114 CPC isolates, 89 (78.1%), 18 (15.8%), and 7 (6.1%) isolates were identified as CPSS, CO, and CM, respectively, by VITEK MS. PCR identified 84 (79.2%), 15 (14.2%), and 7 (6.6%) isolates as CPSS, CO, and CM, respectively. However, PCR did not detect 8 isolates of CPSS detected by VITEK MS. VITEK MS showed 95.3% agreement in species identification and showed a kappa coefficient of 0.87, which is almost perfect agreement. Predominant isolations of all 3 species were from blood. Resistance was observed more in CPSS for both the azoles. Conclusion: MALDI-TOF MS can be used as a rapid, reliable, cost-effective method to identify the species of CPC.


  • Clinical features, diagnosis and treatment outcome of fungal endocarditis: A systematic review of reported cases

    by Durga Shankar Meena, Deepak Kumar, Madhulata Agarwal, Gopal Krishana Bohra, Rahul Choudhary, Subhashree Samantaray, Shivang Sharma, Naresh Midha, Mahendra Kumar Garg

    The landscape of fungal endocarditis (FE) has constantly been evolving in the last few decades. Despite the advancement in diagnostic methods and the introduction of newer antifungals, mortality remains high in FE. This systematic review aimed to evaluate the epidemiology, clinical features, diagnostic and therapeutic interventions in patients with FE. We also aim to examine the aforementioned factors as a determinant of mortality in FE. A literature search was performed in PubMed, Google Scholar and Scopus, and all patients ≥18 years with proven fungal endocarditis were included. A total of 220 articles (250 patients) were included in the final analysis. Candida was the commonest aetiology (49.6%), followed by Aspergillus (30%) and Scedosporium species (3.2%). The proportion of prosthetic valve endocarditis (PVE) and intravenous drug users was 35.2% and 16%, respectively. The overall mortality rate was 40%. On multivariate analysis, Aspergillus endocarditis (HR 3.7, 95% CI 1.4‐9.7; p = .009) and immunocompromised state (HR 2.8, 95% CI 1.24‐6.3; p = .013) were independently associated with mortality. Patients treated with surgery along antifungals had better survival (HR 0.20, 95% CI 0.09‐0.42; p < .001) compared to those treated with antifungals alone. Recurrence of FE was reported in 10.4% of patients. In conclusion, FE carries significant mortality, particularly in immunodeficient and Aspergillus endocarditis. We advocate the use of surgery combined with antifungals to improve clinical outcomes.


  • Open Access

    Demographic Profile of COVID-19 Cases: An Early Analysis of the Local Outbreak in a “Hotspot District” of Western Rajasthan in India

    by Subhashree Samantaray, Vijaya L. Nag, Pankaj Rawat, Sanjeev Misra, Alisha Aggarwal, Salman Khan, Ravisekhar S. Gadepalli, Sarika P. Kombade, Deepak, Naveen Dutt, et al.

    The pandemic of coronavirus disease has created a global emergency after its origin in China, in December 2019. We investigated SARS-CoV-2 infection in the local population of a prime city of Western Rajasthan in India and found that the co-morbidities like diabetes (54.3%), cardiovascular diseases (28.8%), chronic respiratory conditions (18.4%) are the predominant risk factors for acquiring the infection. The young adult male population from urban area were maximum affected by the disease. Most common presenting complains were dry cough (65.7%), fever (62.3%) followed by sore throat (24.1%). A declining positive case percentage was found over the study period, though the number of samples received for SARS-CoV-2 testing increased with time, implying the effectiveness of government policies at community level to spread the outbreak.